|
1
|
Haugen BR, Alexander EK, Bible KC, Doherty
GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM,
Schlumberger M, et al: 2015 American thyroid association management
guidelines for adult patients with thyroid nodules and
differentiated thyroid cancer: The American thyroid association
guidelines task force on thyroid nodules and differentiated thyroid
cancer. Thyroid. 26:1–133. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Pazaitou-Panayiotou K, Michalakis K and
Paschke R: Thyroid cancer in patients with hyperthyroidism. Horm
Metab Res. 44:255–262. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Als C, Gedeon P, Rösler H, Minder C,
Netzer P and Laissue JA: Survival analysis of 19 patients with
toxic thyroid carcinoma. J Clin Endocrinol Metab. 87:4122–4127.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qiu ZL, Shen CT and Luo QY: Clinical
management and outcomes in patients with hyperfunctioning distant
metastases from differentiated thyroid cancer after total
thyroidectomy and radioactive iodine therapy. Thyroid. 25:229–237.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mirfakhraee S, Mathews D, Peng L, Woodruff
S and Zigman JM: A solitary hyperfunctioning thyroid nodule
harboring thyroid carcinoma: Review of the literature. Thyroid Res.
6:72013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Appetecchia M and Ducci M:
Hyperfunctioning differentiated thyroid carcinoma. J Endocrinol
Invest. 21:189–192. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mircescu H, Parma J, Huot C, Deal C,
Oligny LL, Vassart G and Van Vliet G: Hyperfunctioning malignant
thyroid nodule in an 11-year-old girl: Pathologic and molecular
studies. J Pediatr. 137:585–587. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bourasseau I, Savagner F, Rodien P,
Duquenne M, Reynier P, Guyetant S, Bigorgne JC, Malthièry Y and
Rohmer V: No evidence of thyrotropin receptor and G(s alpha) gene
mutation in high iodine uptake thyroid carcinoma. Thyroid.
10:761–765. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Camacho P, Gordon D, Chiefari E, Yong S,
DeJong S, Pitale S, Russo D and Filetti S: A Phe 486 thyrotropin
receptor mutation in an autonomously functioning follicular
carcinoma that was causing hyperthyroidism. Thyroid. 10:1009–1012.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Führer D, Tannapfel A, Sabri O, Lamesch P
and Paschke R: Two somatic TSH receptor mutations in a patient with
toxic metastasising follicular thyroid carcinoma and non-functional
lung metastases. Endocr Relat Cancer. 10:591–600. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wong CP, AuYong TK and Tong CM:
Thyrotoxicosis: A rare presenting symptom of Hurthle cell carcinoma
of the thyroid. Clin Nucl Med. 28:803–806. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Gozu H, Avsar M, Bircan R, Claus M, Sahin
S, Sezgin O, Deyneli O, Paschke R, Cirakoglu B and Akalin S: Two
novel mutations in the sixth transmembrane segment of the
thyrotropin receptor gene causing hyperfunctioning thyroid nodules.
Thyroid. 15:389–397. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Majima T, Doi K, Komatsu Y, Itoh H, Fukao
A, Shigemoto M, Takagi C, Corners J, Mizuta N, Kato R and Nakao K:
Papillary thyroid carcinoma without metastases manifesting as an
autonomously functioning thyroid nodule. Endocr J. 52:309–316.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bitterman A, Uri O, Levanon A, Baron E,
Lefel O and Cohen O: Thyroid carcinoma presenting as a hot nodule.
Otolaryngol Head Neck Surg. 134:888–889. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Niepomniszcze H, Suárez H, Pitoia F,
Pignatta A, Danilowicz K, Manavela M, Elsner B and Bruno OD:
Follicular carcinoma presenting as autonomous functioning thyroid
nodule and containing an activating mutation of the TSH receptor
(T620I) and a mutation of the Ki-RAS (G12C) genes. Thyroid.
16:497–503. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Uludag M, Yetkin G, Citgez B, Isgor A and
Basak T: Autonomously functioning thyroid nodule treated with
radioactive iodine and later diagnosed as papillary thyroid cancer.
Hormones (Athens). 7:175–9. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nishida AT, Hirano S, Asato R, Tanaka S,
Kitani Y, Honda N, Fujiki N, Miyata K, Fukushima H and Ito J:
Multifocal hyperfunctioning thyroid carcinoma without metastases.
Auris Nasus Larynx. 35:432–436. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bommireddipalli S, Goel S, Gadiraju R,
Paniz-MondolFi A and DePuey EG: Follicular variant of papillary
thyroid carcinoma presenting as a toxic nodule by I-123
scintigraphy. Clin Nucl Med. 35:770–775. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Azevedo MF and Casulari LA:
Hyperfunctioning thyroid cancer: A five-year follow-up. Arq Bras
Endocrinol Metabol. 54:78–80. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Giovanella L, Fasolini F, Suriano S and
Mazzucchelli L: Hyperfunctioning solid/trabecular follicular
carcinoma of the thyroid gland. J Oncol. 2010:2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tfayli HM, Teot LA, Indyk JA and Witchel
SF: Papillary thyroid carcinoma in an autonomous hyperfunctioning
thyroid nodule: Case report and review of the literature. Thyroid.
20:1029–1032. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Karanchi H, Hamilton DJ and Robbins RJ:
Hürthle cell carcinoma of the thyroid presenting as thyrotoxicosis.
Endocr Pract. 18:e5–e9. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nair CG, Jacob P, Babu M and Menon R:
Toxic thyroid carcinoma: A new case. Indian J Endocrinol Metab.
16:668–670. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ruggeri RM, Campenni A, Giovinazzo S,
Saraceno G, Vicchio TM, Carlotta D, Cucinotta MP, Micali C,
Trimarchi F, Tuccari G, et al: Follicular variant of papillary
thyroid carcinoma presenting as toxic nodule in an adolescent:
Coexistent polymorphism of the TSHR and Gsα genes. Thyroid.
23:239–242. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Gabalec F, Svilias I, Plasilova I,
Hovorkova E, Ryska A and Horacek J: Follicular variant of papillary
carcinoma presenting as a hyperfunctioning thyroid nodule. J
Pediatr Hematol Oncol. 36:e94–e96. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kuan YC and Tan FH: Thyroid papillary
carcinoma in a ‘hot’ thyroid nodule. QJM. 107:475–476. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Rees DO, Anthony VA, Jones K and Stephens
JW: Follicular variant of papillary thyroid carcinoma: An unusual
cause of thyrotoxicosis. BMJ Case Rep. 2015:2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kadia BM, Dimala CA, Bechem NN and Aroke
D: Concurrent hyperthyroidism and papillary thyroid cancer: A
fortuitous and ambiguous case report from a resource-poor setting.
BMC Res Notes. 9:3692016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Girelli ME, Casara D, Rubello D, Pelizzo
MR, Busnardo B and Ziliotto D: Severe hyperthyroidism due to
metastatic papillary thyroid carcinoma with favorable outcome. J
Endocrinol Invest. 13:333–337. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mizukami Y, Michigishi T, Nonomura A,
Yokoyama K, Noguchi M, Hashimoto T, Nakamura S and Ishizaki T:
Autonomously functioning (hot) nodule of the thyroid gland. A
clinical and histopathologic study of 17 cases. Am J Clin Pathol.
101:29–35. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Russo D, Tumino S, Arturi F, Vigneri P,
Grasso G, Pontecorvi A, Filetti S and Belfiore A: Detection of an
activating mutation of the thyrotropin receptor in a case of an
autonomously hyperfunctioning thyroid insular carcinoma. J Clin
Endocrinol Metab. 82:735–738. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Salvatori M, Rufini V, Corsello SM,
Saletnich I, Rota CA, Barbarino A and Troncone L: Thyrotoxicosis
due to ectopic retrotracheal adenoma treated with radioiodine. J
Nucl Biol Med. 37:69–72. 1993.PubMed/NCBI
|
|
33
|
Sundaraiya S, Dizdarevic S, Miles K, Quin
J, Williams A, Wheatley T and Zammitt C: Unusual initial
manifestation of metastatic follicular carcinoma of the thyroid
with thyrotoxicosis diagnosed by technetium Tc 99m pertechnetate
scan: Case report and review of literature. Endocr Pract.
15:458–462. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Damle NA, Bal C, Kumar P, Soundararajan R
and Subbarao K: Incidental detection of hyperfunctioning thyroid
cancer metastases in patients presenting with thyrotoxicosis.
Indian J Endocrinol Metab. 16:631–636. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gardner D and Ho SC: A rare cause of
hyperthyroidism: Functioning thyroid metastases. BMJ Case Rep.
2014.(pii): bcr2014206468. 2014.PubMed/NCBI
|
|
36
|
Kunawudhi A, Promteangtrong C and
Chotipanich C: A case report of hyperfunctioning metastatic thyroid
cancer and rare I-131 avid liver metastasis. Indian J Nucl Med.
31:210–214. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Abs R, Verhelst J, Schoofs E and De Somer
E: Hyperfunctioning metastatic follicular thyroid carcinoma in
Pendred's syndrome. Cancer. 67:2191–2193. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lorberboym M and Mechanick JI: Accelerated
thyrotoxicosis induced by iodinated contrast media in metastatic
differentiated thyroid carcinoma. J Nucl Med. 37:1532–1535.
1996.PubMed/NCBI
|
|
39
|
Yoshimura Noh J, Mimura T, Kawano M,
Hamada N and Ito K: Appearance of TSH receptor antibody and
hyperthyroidism associated with metastatic thyroid cancer after
total thyroidectomy. Endocr J. 44:855–859. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Guglielmi R, Pacella CM, Dottorini ME,
Bizzarri GC, Todino V, Crescenzi A, Rinaldi R, Panunzi C, Rossi Z,
Colombo L and Papini E: Severe thyrotoxicosis due to
hyperfunctioning liver metastasis from follicular carcinoma:
Treatment with (131)I and interstitial laser ablation. Thyroid.
9:173–177. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Basaria S and Salvatori R: Thyrotoxicosis
due to metastatic papillary thyroid cancer in a patient with
Graves' disease. J Endocrinol Invest. 25:639–642. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Orsolon P, Giachetti M, Lupi A, Salgarello
M, Malfatti V and Zanco P: Pre-therapy hyperfunctioning follicular
thyroid carcinoma evaluation with I-131 whole-body scan and with
F-18 FDG PET/CT. Clin Nucl Med. 33:882–886. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tan J, Zhang G, Xu W, Meng Z, Dong F,
Zhang F, Jia Q and Liu X: Thyrotoxicosis due to functioning
metastatic follicular thyroid carcinoma after twelve I-131
therapies. Clin Nucl Med. 34:615–619. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Nishihara E, Amino N and Miyauchi A:
Fractionated radioiodine therapy for hyperthyroidism caused by
widespread metastatic follicular thyroid carcinoma. Thyroid.
20:569–570. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Lim H, Devesa SS, Sosa JA, Check D and
Kitahara CM: Trends in thyroid cancer incidence and mortality in
the United States, 1974–2013. JAMA. 317:1338–1348. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Salih AM, Kakamad FH and Nihad H:
Hyperfunctioning papillary thyroid carcinoma: A case report with
literature review. Int J Surg Case Rep. 26:202–204. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Pringle DR, Yin Z, Lee AA, Manchanda PK,
Yu L, Parlow AF, Jarjoura D, La Perle KM and Kirschner LS:
Thyroid-specific ablation of the Carney complex gene, PRKAR1A,
results in hyperthyroidism and follicular thyroid cancer. Endocr
Relat Cancer. 19:435–446. 2012. View Article : Google Scholar : PubMed/NCBI
|
